Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Changes in Beneficial Ownership · 4

Bausch + Lomb Corporation

Changes in Beneficial Ownership

Filed Nov 2, 2026Accepted Nov 2, 2026, 4:18 PM ESTFiling CIK 1860742Accession 0001860742-26-000114
Share

Structured filing — 4

form4.xml

Open full document ↗

Filing details

Report period
2026-10-29
Issuer
Bausch & Lomb Corp
Issuer CIK
0001860742
Trading symbol
BLCO

Reporting owner 1

Name
ROBERTSON RUSSEL C
Reporting owner CIK
0001677301
Relationship
Director
Address
C/O BAUSCH + LOMB CORPORATION, 520 APPLEWOOD CRESCENT, VAUGHAN, ONTARIO, CANADA, A6, L4K 4B4

Non-derivative transactions

Non-derivative transactions · 1 reported row
SecurityTransaction dateCodeAmountA / DPrice (USD)Owned afterOwnership
Common Shares, No Par Value2026-10-29A · Form 41,256[F1]A20.4095,516D
Table key
A · Form 4
Acquisition by grant, award or otherwise under Rule 16b-3(d)
A
Acquired
D
Direct

Footnotes

F1
Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation.↩ 1

Signature 1

Signed
/s/ Debra E. Levin, attorney-in-fact
Date
2026-11-02

Company context

Our mission is simple - we help people see better to live better, all over the world. For nearly two centuries we’ve evolved with the changing needs of patients and customers, and our commitment to innovation and improving the standard of care in eye health has never been stronger. From contact lenses to prescription products, over-the-counter options, surgical devices and more, we’re turning bold ideas into better outcomes through passion, perseverance and purpose. Learn more at www.bausch.com and connect with us on Facebook, Instagram, LinkedIn, X and YouTube.

Current securities

Recent company filings

  1. 4 filingNov 2, 2026
  2. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsOct 28, 2026
  3. 10-Q filingOct 28, 2026
  4. Results of Operations and Financial ConditionOct 28, 2026
  5. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD DisclosureOct 13, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.